Catalys Pacific, LLC
13F holdings for Q2 2026 · TOKYO, M0 · filed August 5, 2026
Catalys Pacific, LLC reported $229M in 13F securities across 2 holdings for Q2 2026, in a Form 13F filed August 5, 2026. The largest positions were MLYS (92.9%), PHAT (7.1%). Reported value fell 0.5% from the quarter before.
- 13F value Q2 2026
- $229M
- Holdings
- 2
- Change vs prior quarter
- -0.5%
- Rank by 13F value
- #6,089
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Top holdings
| Stock | Value | Weight | Shares | Change in shares | Move |
|---|---|---|---|---|---|
| MLYS Mineralys Therapeutics Inc. | $213M | 92.9% | 7,903,838 | 0% | Unchanged |
| PHAT Phathom Pharmaceuticals Inc. | $16.2M | 7.1% | 1,493,854 | 0% | Unchanged |
Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $229M in share positions; options and bonds count in the 13F value but not here.
Biggest buys in Q2 2026
None this quarter.
Biggest sells in Q2 2026
None this quarter.
The change in shares since Q1 2026, adjusted for stock splits and priced at the Q2 2026 value per share. 0 new, 0 added, 0 trimmed, 0 sold out.
13F value by quarter
Questions about Catalys Pacific, LLC
- What does Catalys Pacific, LLC own?
- In its Form 13F for Q2 2026, Catalys Pacific, LLC reported 2 holdings worth $229M. The five largest were MLYS, PHAT.
- What did Catalys Pacific, LLC buy and sell in Q2 2026?
- Catalys Pacific, LLC opened 0 new positions, added to 0, trimmed 0 and sold out of 0 compared with the quarter before.
- When did Catalys Pacific, LLC file its latest 13F?
- Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed August 5, 2026.
From Form 13F filed by Catalys Pacific, LLC (SEC CIK 0002011385) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds